Please use this identifier to cite or link to this item:
http://hdl.handle.net/10553/48611
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Esteve-Solé, Ana | en_US |
dc.contributor.author | Sologuren, Ithaisa | en_US |
dc.contributor.author | Martínez-Saavedra, María Teresa | en_US |
dc.contributor.author | Deyà-Martínez, Àngela | en_US |
dc.contributor.author | Oleaga-Quintas, Carmen | en_US |
dc.contributor.author | Martinez-Barricarte, Rubén | en_US |
dc.contributor.author | Martin-Nalda, Andrea | en_US |
dc.contributor.author | Juan, Manel | en_US |
dc.contributor.author | Casanova, Jean Laurent | en_US |
dc.contributor.author | Rodriguez-Gallego, Carlos | en_US |
dc.contributor.author | Alsina, Laia | en_US |
dc.contributor.author | Bustamante, Jacinta | en_US |
dc.date.accessioned | 2018-11-23T23:22:18Z | - |
dc.date.available | 2018-11-23T23:22:18Z | - |
dc.date.issued | 2018 | en_US |
dc.identifier.issn | 1040-8363 | en_US |
dc.identifier.uri | http://hdl.handle.net/10553/48611 | - |
dc.description.abstract | The integrity of the interferon (IFN)-γ circuit is necessary to mount an effective immune response to intra-macrophagic pathogens, especially Mycobacteria. Inherited monogenic defects in this circuit that disrupt the production of, or response to, IFN-γ underlie a primary immunodeficiency known as Mendelian susceptibility to mycobacterial disease (MSMD). Otherwise healthy patients display a selective susceptibility to clinical disease caused by poorly virulent mycobacteria such as BCG (bacille Calmette-Guérin) vaccines and environmental mycobacteria, and more rarely by other intra-macrophagic pathogens, particularly Salmonella and M. tuberculosis. There is high genetic and allelic heterogeneity, with 19 genetic etiologies due to mutations in 10 genes that account for only about half of the patients reported. An efficient laboratory diagnostic approach to suspected MSMD patients is important, because it enables the establishment of specific therapeutic measures that will improve the patient’s prognosis and quality of life. Moreover, it is essential to offer genetic counseling to affected families. Herein, we review the various genetic and immunological diagnostic approaches that can be used in concert to reach a molecular and cellular diagnosis in patients with MSMD. | en_US |
dc.language | eng | en_US |
dc.relation.ispartof | Critical Reviews in Clinical Laboratory Sciences | en_US |
dc.source | Critical Reviews in Clinical Laboratory Sciences[ISSN 1040-8363],v. 55, p. 184-204 (Marzo 2018) | en_US |
dc.subject | 32 Ciencias médicas | en_US |
dc.subject | 3201 Ciencias clínicas | en_US |
dc.subject.other | Mycobacteria | en_US |
dc.subject.other | Intracellular pathogens | en_US |
dc.subject.other | Interferon gamma | en_US |
dc.subject.other | Primary immunodeficiency | en_US |
dc.subject.other | Diagnosis | en_US |
dc.subject.other | MSMD | en_US |
dc.title | Laboratory evaluation of the IFN-γ circuit for the molecular diagnosis of Mendelian susceptibility to mycobacterial disease | en_US |
dc.type | info:eu-repo/semantics/review | en_US |
dc.type | Article | en_US |
dc.identifier.doi | 10.1080/10408363.2018.1444580 | en_US |
dc.identifier.scopus | 85044630483 | - |
dc.contributor.authorscopusid | 57112530700 | - |
dc.contributor.authorscopusid | 36451076500 | - |
dc.contributor.authorscopusid | 56231072200 | - |
dc.contributor.authorscopusid | 48561014500 | - |
dc.contributor.authorscopusid | 57190754358 | - |
dc.contributor.authorscopusid | 16507099700 | - |
dc.contributor.authorscopusid | 26026011600 | - |
dc.contributor.authorscopusid | 7006971346 | - |
dc.contributor.authorscopusid | 56562475800 | - |
dc.contributor.authorscopusid | 6602114379 | - |
dc.contributor.authorscopusid | 6507744450 | - |
dc.contributor.authorscopusid | 57201082594 | - |
dc.description.lastpage | 204 | en_US |
dc.description.firstpage | 184 | en_US |
dc.relation.volume | 55 | en_US |
dc.investigacion | Ciencias de la Salud | en_US |
dc.type2 | Reseña | en_US |
dc.description.numberofpages | 21 | en_US |
dc.utils.revision | Sí | en_US |
dc.date.coverdate | Marzo 2018 | en_US |
dc.identifier.ulpgc | Sí | en_US |
dc.identifier.ulpgc | Sí | en_US |
dc.identifier.ulpgc | Sí | en_US |
dc.identifier.ulpgc | Sí | en_US |
dc.contributor.buulpgc | BU-MED | en_US |
dc.description.sjr | 1,905 | - |
dc.description.jcr | 4,817 | - |
dc.description.sjrq | Q1 | - |
dc.description.jcrq | Q1 | - |
dc.description.scie | SCIE | - |
item.grantfulltext | none | - |
item.fulltext | Sin texto completo | - |
crisitem.author.dept | GIR IUIBS: Farmacología Molecular y Traslacional | - |
crisitem.author.dept | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.dept | Departamento de Ciencias Médicas y Quirúrgicas | - |
crisitem.author.orcid | 0000-0002-4344-8644 | - |
crisitem.author.parentorg | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.fullName | Rodríguez Gallego, José Carlos | - |
Appears in Collections: | Reseña |
Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.